A20 is a Cys 2 /Cys 2 zinc ®nger protein which is induced by a variety of in¯ammatory stimuli and which has been characterized as an inhibitor of cell death by a yet unknown mechanism. In order to clarify its molecular mechanism of action, we used the yeast two-hybrid system to screen for proteins that interact with A20. A cDNA fragment was isolated which encoded a portion of a novel protein (TXBP151), which was recently found to be a human T-cell leukemia virus type-I (HTLV-I) Taxbinding protein. The full-length 2386 bp TXBP151 mRNA encodes a protein of 86 kDa. Like A20, overexpression of TXBP151 could inhibit apoptosis induced by tumour necrosis factor (TNF) in NIH3T3 cells. Moreover, transfection of antisense TXBP151 partially abolished the anti-apoptotic eect of A20. Furthermore, apoptosis induced by TNF or CD95 (Fas/ APO-1) was associated with proteolysis of TXBP151. This degradation could be inhibited by the broadspectrum caspase inhibitor zVAD-fmk or by expression of the cowpox virus-derived inhibitor CrmA, suggesting that TXBP151 is a novel substrate for caspase family members. TXBP151 was indeed found to be speci®cally cleaved in vitro by members of the caspase-3-like subfamily, viz. caspase-3, caspase-6 and caspase-7. Thus TXBP151 appears to be a novel A20-binding protein which might mediate the anti-apoptotic activity of A20, and which can be processed by speci®c caspases.
Introduction
A20 is a primary response gene which was originally identi®ed as a cytokine-inducible gene in human umbilical vein endothelial cells . Subsequent research demonstrated that A20 is not only induced in endothelial cells by bacterial lipopolysaccharide or by the cytokines, tumour necrosis factor (TNF) and interleukin-1 (IL-1), but also by other stimuli in other cell types. These include the EpsteinBarr virus LMP1 gene product (Laherty et al., 1992) and the B-cell surface receptor CD40 (Sarma et al., 1995) , as well as the human T-cell leukemia virus type-I (HTLV-I) Tax protein and phorbol 12-myristate 13-acetate (Laherty et al., 1993) in Jurkat T-cells. Superinduction of the A20 gene can often be observed by co-stimulation with cycloheximide. Remarkably, the same gene has been isolated as a monocyte adherence cDNA clone, and has therefore also been called MAD6 (Sporn et al., 1990) . Besides its initial characterization as an inhibitor of TNF-induced apoptosis , A20 is also a potent cellular inhibitor of NFkB activation (Cooper et al., 1996; JaÈ aÈ ttelaÈ et al., 1996; Song et al., 1996; Heyninck et al., 1999) .
The molecular mechanism of action responsible for A20-mediated inhibition of apoptosis or NF-kB activation is, at present, largely unknown. The human A20 gene encodes a 790 amino acids-containing protein, consisting of a C-terminal domain with seven Cys 2 /Cys 2 zinc ®ngers (Opipari et al., 1990) . Because of the presence of these zinc ®ngers, A20 has been postulated to function as a transcriptional modulator, but speci®c DNA binding has never been demonstrated. Recently, using the yeast two-hybrid system, we and others have demonstrated that A20 is able to self-associate by its zinc ®nger domain (De Valck et al., 1996; Song et al., 1996) , indicating a role for the seven Cys 2 /Cys 2 zinc ®ngers in protein-protein interaction. Indeed, a heterotypic protein-protein interaction between A20 and the TNF receptor-associated proteins TRAF1 and TRAF2 (Song et al., 1996; Heyninck et al., 1999) , as well as between A20 and several isoforms of 14 ± 3 ± 3 proteins has been documented (Vincenz and Dixit, 1996; De Valck et al.,1997) . In this report we describe the interaction of A20 with a novel protein which was recently isolated as a HTLV-I Tax-binding protein (TXBP151) by two independent groups (Jin et al., 1997, GenBank Accession number U33821; Gachon et al., 1998) . The biological role of TXBP151, which encodes a widely expressed protein of 86 kDa, is still unknown. Here, we present evidence that TXBP151 might mediate the antiapoptotic activity of A20. Moreover, we also demonstrate that TXBP151 is a novel substrate for caspase-3-like proteases in TNF and CD95 (Fas/APO-1)-induced apoptosis.
the human zinc ®nger protein A20 was performed using the yeast two-hybrid system as described previously (De Valck et al., 1996) . An expression vector encoding human A20 fused to the DNA-binding domain of the yeast transcription factor GAL4 was used as a bait. 1.3610 6 individual yeast transformants were screened, and 11 clones were found to express candidate A20-associating protein fragments, as determined by activation of his and lacZ reporter genes. After sequencing and BLAST searches, one of the cDNA inserts was found to encode the 361 Cterminal amino acid residues of a protein which was previously isolated as a HTLV-I Tax-binding protein, viz. TXBP151. (GenBank accession No. U33821; Jin et al., unpublished data) . Recently, the interaction of Tax with TXBP151 has been con®rmed independently by another research group (Gachon et al., 1998) . However, the characterisation of TXBP151 as well as its biological function has yet to be achieved. In the present paper we focused further on its biological and functional interaction with A20. To con®rm the speci®city of our two-hybrid approach, the pGAD424 yeast expression vector containing the isolated TXBP151 cDNA fragment was retransformed into Saccharomyces cerevisiae strain HF7c, together with either an empty pAS2 yeast expression vector, pAS2 containing full-length A20 cDNA (pAS2A20), A20 cDNA fragments encoding amino acids 1 ± 367 or 373 ± 790 (pAS2A20ZF 7 and pAS2A20ZF + , respectively), or plasminogen activator inhibitor-2 as an irrelevant cDNA (pAS2PAI2) ( Table 1) . Since histidine (His) prototrophy and b-galactosidase (bGal) activity were observed only in yeast colonies cotransformed with the TXBP151 cDNA fragment and either fulllength A20 cDNA or A20ZF + cDNA, we conclude that the interaction of A20 and TXBP151 is speci®c and is mediated via the C-terminal half of A20, which spans the domain containing the seven Cys 2 /Cys 2 zinc ®ngers.
The full-length human TXBP151 cDNA was isolated from a HeLa cell cDNA library and revealed an open reading frame predicted to encode a protein of 747 amino acids (86 kDa) ( Figure 1a ). This is longer than the originally deposited TXBP151 sequence in the GenBank, suggesting the existence of two forms of messenger RNAs. Indeed, Northern blot analysis revealed that TXBP151 mRNA was expressed in various human cell lines as 1.9 kb and 2.4 kb species, the former probably being a shorter splicing variant ( Figure 1b) . Transfection of the two open reading frames in human embryonic kidney HEK293T cells produced two forms of TXBP151 protein (data not shown), which are further referred to as`large' (TXBP151-L) and`small' (TXBP151-S), according to their respective molecular masses of 86 kDa and 68 kDa. However, analysis of the endogenous expression of TXBP151 by Western blotting with a polyclonal antibody raised against the C-terminus of TXBP151 showed only a single 86 kDa protein in various human cell lines (Figure 1c) , suggesting regulated expression of TXBP151-L. Besides a putative 14 ± 3 ± 3-binding motif (   112   RGASTP   117 ; Muslin et al., 1996) , no distinctive protein domains were found. No signi®cant homology with other known proteins could be detected, except for the N-terminal region of TXBP151-L which was found to be homologous to nuclear dot protein 52 (NDP52; Korioth et al., 1995) .
The interaction of TXBP151 with A20 was further analysed using mammalian cell co-immunoprecipitation assays. TXBP151-L or TXBP151-S were transiently co-expressed in HEK293T cells with A20 containing an N-terminal E-tag. Immunoprecipitation of the 90 kDa A20 protein with an anti-E-tag monoclonal antibody, followed by immunoblot analysis with a polyclonal antibody raised against the Cterminus of TXBP151 (anti-TXBP151-C), revealed that A20 co-immunoprecipitated with both TXBP151-L and TXBP151-S (Figure 2 ). This con®rms the interaction originally detected by the yeast two-hybrid analysis.
TXBP151 has anti-apoptotic properties A20 was initially characterized as an inhibitor of TNFinduced apoptosis in several cell lines JaÈ aÈ ttelaÈ et al., 1996) . A20's anti-apoptotic activity seems to be restricted to certain cells (JaÈ nicke et al., 1994; Natoli et al., 1998) . To analyse whether TXBP151 might mediate the anti-apoptotic activity of A20, we transiently transfected four cell lines with either A20 or TXBP151, and measured cellular sensitivities to TNF-induced apoptosis. Among the dierent cell lines (A549, HeLa, HepG2 and NIH3T3) we found an inhibitory eect on TNF-induced apoptosis by A20 overexpression in only NIH3T3 cells, which is in agreement with the earlier reported cell line-speci®c protective eect of A20. Similar to A20, overexpression of TXBP151 also inhibited TNFinduced apoptosis in NIH3T3 cells, but not in any of the other three cell lines tested (Figure 3 ; data are only shown for A549 and NIH3T3). In contrast to A20 and TXBP151, the cowpox virus-derived CrmA gene, which was previously shown to be a pseudo-substrate inhibitor for speci®c caspases (Los et al., 1995; Tewari and Dixit, 1995) , completely inhibited TNF-induced apoptosis in a cell line independent manner. Most interestingly, the anti-apoptotic eects of both TXBP151 and A20 in NIH3T3 cells was partially blocked by co-expressing in the cells an antisense TXBP151 cDNA. This suggests that TXBP151 mediates at least one part of the anti-apoptotic eects of A20. The inability of A20 to exert its protective eect in some cells was not due to the absence of endogenous expression of TXBP151, since co-expres- 
Survey of His prototrophy (tested in the presence of 5 mM 3-amino-1,2,3-triazole) and bGal activity after cotransformation of S. cerevisiae strain HF7c with dierent yeast expression vectors as indicated. A20, A20ZF 7 and A20ZF + are full-length, C-terminaldeleted and N-terminal-deleted A20 cDNA fragments, respectively (De Valck et al., 1996) . PAI2 represents plasminogen activator inhibitor-2 cDNA. TXBP151 is a cDNA fragment encoding the 361 C-terminal amino acid residues of the protein. Cotransformation was veri®ed by growth on appropriate minimal synthetic media sion of A20 with transfected TXBP151 also failed to reduce sensitivity of HeLa or HepG2 cells to TNF (data not shown). In addition, immunoblot analysis directly demonstrated that considerable amounts of endogeneous TXBP151 exist in all cell lines tested ( Figure 1c and data not shown).
TXBP151 is a substrate for caspase-3-like proteases in TNF and CD95 (Fas/APO-1)-induced apoptosis
In the course of the above studies, we observed that TXBP151 was frequently degraded when cells were subjected to apoptosis. Hence we examined in detail the eect of the apoptotic stimuli TNF and anti-CD95 (Fas/APO-1) on endogenous TXBP151 in HeLa cells that were sensitized to TNF and anti-CD95 by the transcription inhibitor actinomycin D. Apoptosis was assessed by internucleosomal DNA fragmentation ( Figure 4a ) as well as by morphological changes observed by microscopy (data not shown). Immunoblot analysis of cell extracts from non-treated or actinomycin D-treated HeLa cells with anti-TXBP151-C, which recognizes the C-terminus of TXBP151, revealed a band of 86 kDa corresponding to TXBP151-L (Figure 4b ). The lower migrating bands are proteins which are non-speci®cally recognized by the antibody. Upon induction of apoptosis with TNF or anti-CD95, TXBP151 could no longer be detected in the cell extracts (Figure 4b ). Although in this setting we were unable to observe discrete cleavage products, the disappearance of TXBP151 is likely a result of proteolytic cleavage. The failure to detect cleavage products might be due to their instability and/or lack of recognition by the anti-TXBP151-C antibody.
Since activation of the caspase family of proteases is recognized as a key event in the regulation and execution of apoptosis (Thornberry and Lazebnik, 1998) , we next examined whether caspases are involved in TXBP151 degradation. Pretreatment of HeLa cells with the broad-spectrum tripeptide caspase inhibitor zVAD-fmk (Fearnhead et al., 1995; Pronk et al., 1996) completely inhibited both TNF and anti-CD95-induced TXBP151 degradation (partially shown in Figure 5 ) as well as apoptosis (data not shown). Similarly, stable expression of the cowpox virus-derived CrmA gene also partially inhibited TNF and anti-CD95-induced TXBP151 proteolysis and apoptosis ( Figure 5 ). These results support a role for caspases in TXBP151 proteolysis during apoptosis.
Currently, more than 10 dierent mammalian caspases have been characterized. These can be divided in three subfamilies, designated as caspase-1-like, caspase-2-like and caspase-3-like proteases (Alnemri et al., 1996; Van de Craen et al., 1997; Thornberry and Lazebnik, 1998) . Each subfamily displays distinct substrate speci®cities and may play separate roles in apoptosis. To determine which caspase(s) might be responsible for TXBP151 proteolysis, we performed in vitro cleavage assays with puri®ed recombinant caspases and in vitro transcribed/translated TXBP151 as a substrate.
Three out of seven caspases tested cleaved TXBP151 in vitro (Figure 6 ). These include caspase-3 and caspase-7, which resulted in similar but complex TXBP151 degradation patterns. Additional studies with a dilution of caspase-3 and caspase-7 revealed that lower amounts (3 ng) of caspase speci®cally produced the slower migrating degradation products (data not shown), suggesting that the observed smaller fragments might be the result of non-speci®c cleavage. Caspase-6 only resulted in the removal of a small peptide from TXBP151. Interestingly, caspase-3, caspase-6 and caspase-7 belong to the same caspase-3-like subfamily. Thus, both in vivo and in vitro data consistently suggest that TXBP151 is a novel substrate for caspase-3-like proteases in TNF and CD95-induced apoptosis. In contrast, A20 was not cleaved by any of the caspases tested (data not shown).
Discussion
Since the initial characterization of the zinc ®nger protein A20 as a primary response gene induced by TNF and the observation that A20 can act both as an inhibitor of cell death and NF-kB activation Cooper et al., 1996; JaÈ aÈ ttelaÈ et al., 1996; Song et al., 1996) , the number of stimuli that induce A20 has increased considerably. These include IL-1, lipopolysaccharide, phorbol 12-myristate 13-acetate, CD40, and the viral proteins LMP1 and Tax Laherty et al., 1992 Laherty et al., , 1993 Sarma et al., 1995; Zen et al., 1998) . However, the molecular mechanism accounting for the inhibitory function of A20 remains largely unknown. Identi®cation of cellular proteins that can interact with A20 might shed some light on this question. Here we have used the yeast two-hybrid system to screen a cDNA library for A20-interacting proteins. We found that A20 is able to interact with a novel protein (TXBP151) which was recently independently isolated as a binding protein for HTLV-I Tax (Gachon et al., 1998; Jin et al., unpublished data) . Currently, the biological function of Tax-TXBP151 binding is not known.
While A20 is only expressed in stimulated cells, TXBP151 is constitutively expressed in human cells as The arrow points to a TXBP151-speci®c band recognized by the TXBP151-C antibody. A duplicate Western blot using pre-immune serum did not detect any TXBP151-speci®c reactivity (data not shown). Relative intensities of the TXBP151-speci®c bands in lanes 1 ± 4 are 1.0, 2.3, 2.6 and 1.2, respectively an 86 kDa protein. A20 associates with TXBP151 through the C-terminal zinc ®nger containing domain of A20, which has previously been shown to be crucial for inhibition of NF-kB activation (Song et al., 1996) . Similarly, this domain also mediates the anti-apoptotic activity of A20 (our unpublished observations). We report here that TXBP151 may eect at least a part of these anti-apoptotic eects of A20. It should be noted (as we con®rm here) that A20-mediated inhibition of apoptosis is not a universal mechanism which is used by all cells. Hence, protection against TNF cytotoxicity exists for MCF7, WEHI164 and NIH3T3 cells, but not for HeLa cells JaÈ nicke et al., 1994; Natoli et al., 1998) . Consistent with this, we did not observe inhibition of TNF-induced apoptosis upon A20 overexpression in A549, HeLa or HepG2 cells. However, NIH3T3 cells were partially protected by A20 overexpression. Interestingly, overexpression of TXBP151 also inhibited TNF-induced apoptosis in NIH3T3 but not in A549, HeLa, nor HepG2 cells. The latter observation as well as the fact that A20 binds TXBP151 correlates TXBP151 function with the antiapoptotic activity of A20. This hypothesis is further strengthened by our ®nding that transfection with antisense TXBP151 cDNA could partially prevent the anti-apoptotic activity of A20. The reason why A20 and TXBP151 are only anti-apoptotic in a limited number of cell lines is still unclear. Remarkably, A20 could prevent TNF-induced NF-kB activation in all cell lines analysed (Natoli et al., 1998; Heyninck et al., 1999) , suggesting that A20 regulates apoptosis and NFkB activation by a dierent mechanism.
The inability of A20 to inhibit apoptosis in some cells is not due to the absence of TXBP151 expression. The latter is clearly expressed in all cell lines analysed in this study. Moreover, simple co-expression of A20 with TXBP151 did not always induce protection. Thus, one might speculate that another necessary endogenous protein is insuciently expressed in those cell lines which are not responsive to A20 or TXBP151. Because most cell lines are rather resistant to TNF-induced apoptosis, it is likely that several other anti-apoptotic proteins such as Bcl-2 (Hennet et al., 1993) or inhibitor of apoptosis proteins (IAP and XIAP; Liston et al., 1996) are involved in TNF resistance. Alternatively, dierent cell type-speci®c pathways for induction of apoptosis may exist, only some of which are aected by A20 expression. The underlaying mechanism of TNF resistance by A20 and TXBP151 is unknown. A20 has been shown to bind to TRAF1 and TRAF2 which are recruited to the TNF receptor complex upon stimulation (Song et al., 1996) . Therefore, binding to A20 might provide a molecular mechanism by which TXBP151 can interfere with an early event in the TNF signaling pathway. The identi®cation of TXBP151 interacting proteins may shed further light on this. In addition, TXBP151 contains a speci®c consensus sequence for binding to 14 ± 3 ± 3 proteins, which might act as adaptors between TXBP151 and proteins of the TNF signaling pathway.
Interestingly, TNF and CD95-induced apoptosis was found to be associated with speci®c proteolysis of TXBP151 by proteases of the caspase family. Caspases are cysteine proteases that cleave their substrates after aspartate residues and play key roles in apoptosis and in¯ammation (Thornberry and Lazebnik, 1998) . Diverse structural and regulatory proteins and enzymes undergo speci®c endoproteolytic cleavage by various caspases during apoptosis (Porter et al., 1997; Widmann et al., 1998) . TXBP151 seems to be speci®cally cleaved by members of the caspase-3 subfamily, which are believed to be the eector caspases during the apoptotic process. The presence of multiple cleavage products after incubation of TXBP151 with caspase-3, caspase-6 and caspase-7 in vitro is partially due to the fact that uncleaved in vitro transcribed/translated TXBP151 originates as a doublet resulting from internal initiation of translation. Some of the cleavage products probably also result from cleavage of TXBP115 at multiple sites. Recently, the speci®cities of members of the caspase family have been determined (Nicholson and Thornberry et al., 1997) . Interestingly, caspase-3 and caspase-7 showed an identical substrate preference, while caspase-6 prefered a slightly dierent peptide sequence. These results are in agreement with our ®nding that caspase-3 and caspase-7 generate similar cleavage products of TXBP151, while the eect of caspase-6 was quite dierent. The inhibition of TXBP151 cleavage by CrmA expression is presumably due to inhibition of caspases which act upstream of caspase-3 and caspase-7, because the latter caspases are only weakly inhibited by CrmA (Zhou et al., 1997) . This would ®t with the generally accepted model in which the CrmA-sensitive caspase-8 acts as an upstream caspase early in TNF signaling. As with most identi®ed caspase substrates, the functional signi®cance of the cleavage of TXBP151 is still unclear. Some caspase substrates are activated upon cleavage, whereas others are inactivated. Bcl-2 and Bcl-X L , two anti-apoptotic proteins, are also cleaved by caspases, at least during some types of apoptotic cell deaths (Cheng et al., 1997; Fujita et al., 1998) . In these cases, caspase cleavage generates a fragment which promotes rather than antagonizes cell death. Similarly, caspase-dependent cleavage of the CrmA were treated for 18 h with actinomycin D (1 mg/ml) in combination with TNF (1000 IU/ml). TXBP151 degradation was demonstrated by separating 250 mg of total cellular protein on a 12% SDS ± polyacrylamide gel and by Western blotting using anti-TXBP151-C antibody. TXBP151 levels were slightly higher in zVAD-fmk-pretreated or CrmA-expressing cells due to inhibition of actinomycin D-induced apoptosis and proteolysis of TXBP151 Figure 6 In vitro caspase assay using TXBP151 as a substrate.
35
S-methionine-labeled TXBP151-S (1 ml) was mixed with dierent puri®ed caspase preparations (300 ng) in caspase maturation buer (18 ml) and incubated for 1.5 h at 378C. Proteolysis was analysed by 12% SDS ± PAGE and autoradiography. The main degradation products detectable at a lower caspase concentration (3 ng) are indicated by arrowheads protein kinases Akt and Raf-1 has recently been described as a mechanism to suppress survival pathways (Widmann et al., 1998) . Because TXBP151 cleavage leads to multiple processed products, it is tempting to speculate that caspase-mediated cleavage of TXBP151 also serves to turn-o its anti-apoptotic function. Future studies with uncleavable mutants of TXBP151 will be required to evaluate this hypothesis.
In conclusion, the present study demonstrates that the zinc ®nger protein A20 interacts with a novel protein which mediates the anti-apoptotic eect of A20, and which is cleaved by caspase-3-like proteases during TNF and CD95-induced apoptosis. Further attempts to characterize the functional role of its processing, as well as the exact biological mechanism by which TXBP151 regulates apoptosis are in progress. Finally, because this novel A20-binding protein also binds to the HTLV-I oncoprotein Tax, it will be important to understand whether it serves a role in Tax-mediated transformation and DNA-damage. (Majone et al., 1993; Jin et al., 1998; Rosin et al., 1998) .
Materials and methods

Cell lines and materials
Human embryonic HEK293T cells were a kind gift of Dr M Hall (University of Birmingham, UK). Human lung carcinoma A549, human hepatoma HepG2, human cervix carcinoma HeLa cells and mouse NIH3T3 ®broblasts originated from the ATCC collection. Human TNF was produced by E. coli and puri®ed to at least 99% homogeneity. Agonistic anti-CD95 (Fas/APO-1) monoclonal antibodies of the IgM type (clone CH-11) were purhased from ImmunoTech (Alston, MA, USA). Cycloheximide and actinomycin D were obtained from Sigma Chemical Co. (St Louis, MO, USA). The cowpox virus-derived CrmA cDNA was a kind gift of Dr D Pickup (Duke University Medical Centre, Durham, NC, USA). The tripeptide caspase inhibitor zVAD-fmk was purchased from Enzyme Systems Products (Dublin, CA, USA). Anti-E-tag monoclonal antibody was obtained from Pharmacia Biotech (Uppsala, Sweden). Anti-TXBP151-C polyclonal antibody was obtained by immunizing rabbits with the KLH-conjugated peptide corresponding to the C-terminal 23 residues DYDQQVFERHVQTHF-DQNVLNFD. Anti-mouse and anti-rabbit horseradish peroxidase-linked antibodies, as well as an ECL Western blotting detection kit were purchased from Amersham International (Amersham, UK). Protein A-linked trisacryl beads were from Pierce Chemicals (Rockford, IL, USA). 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside was from Saxon Biochemicals (Hannover, Germany).
Yeast two-hybrid system
The Matchmaker yeast two-hybrid system was purchased from Clontech Laboratories (Palo Alto, CA, USA). L929r2 cDNA library screening or co-transformation of putative interacting proteins was performed as described previously (De Valck et al., 1996) . cDNA inserts encoding candidate A20-associating protein fragments were sequenced on both strands with a cycle sequencer (Applied Biosystems, Foster City, CA, USA). BLAST searches were conducted using the NCBI on-line service.
The cloning of full-length, C-terminal-deleted and Nterminal-deleted A20 cDNA into the pAS2 yeast expression vector, referred to as pAS2A20, pAS2A20ZF 7 and pAS2A20ZF + , respectively, was described previously (De Valck et al., 1996) . pAS2A20ZF 7 spans the domain lacking the seven Cys 2 /Cys 2 zinc ®ngers, whereas pAS2A20ZF + spans the domain containing the seven Cys 2 /Cys 2 zinc ®ngers.
Cloning of human TXBP151 cDNA TXBP151 cDNA was initially isolated from a HeLa S3 cell line Matchmaker cDNA library (Clontech Laboratories) in a yeast two-hybrid screen using HTLV-I Tax as a bait. The bait plasmid based on pGBT9-Tax (Clontech Laboratories) has been previously described . The initial TXBP151 clone contains a 1756 bp human cDNA which encodes the TXBP151-S protein binding to Tax. A 2386 bp full-length TXBP151 cDNA was constructed with the 5' sequence obtained from the same cDNA library using the 5' RACE (rapid ampli®cation of cDNA ends) procedure. The same 2.4 kb cDNA was also obtained from a brain and a thymus cDNA library (Institute for Genomic Research, Rockville, MD, USA).
Northern blot analysis
A Northern blot from human cell lines was probed with a 32 P-labeled, 1.8 kb 3' TXBP151 fragment as described by the manufacturer (Clontech Laboratories). Radioactivity on the Northern blot was quantitated with a Fuji FLA-2000 phosphorimager.
Coimmunoprecipitation and Western blotting
HEK293T cells were grown in 10-cm Petri dishes and transiently transfected using the DNA calcium phosphate coprecipitation method as described (O'Mahoney and Adams, 1994) . After 18 h, the DNA precipitate was washed away and cells were left untreated for 24 h. Cells were lysed in 20 mM Tris-HCl pH 7.5, 1% Triton X-100, 137 mM NaCl, 1.5 mM MgCl 2 and 1 mM EGTA, supplemented with protease and phosphatase inhibitors. Immunoprecipitation with anti-E-tag antibodies and absorption onto protein A-linked trisacryl beads was followed by 12% SDS ± PAGE and blotting onto a nitrocellulose membrane (Schleicher and Schuell, Dassel, Germany) . Proteins were detected with primary antibodies recognizing the E-tag or the C-terminus of the TXBP151 protein. Anti-mouse or anti-rabbit horseradish peroxidaselinked antibodies were used as secondary antibodies, and detection was performed by the ECL method (Amersham International).
Detection of apoptosis during transient transfections
10
7 cells were transiently transfected with 5 mg of a bGal encoding plasmid (pUT651; Cayla, Toulouse, France) and 10 mg pCAGGS encoding the indicated cDNAs, using electroporation (300 V, 1500 C). Cells were left untreated for 48 h, while dead cells due to electroporation were washed away daily. Following stimulation for 6 h with TNF in the presence of cycloheximide, cells were stained with 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside as described (Chinnayian et al., 1996) . The amount of apoptotic cells was determined as the percentage of cells showing apoptotic morphology (membrane blebbing) within the total population of transfected cells (stained blue).
Detection of apoptosis by electrophoretic analysis of cellular DNA DNA isolation and agarose gel electrophoresis were performed essentially as described (Rubin et al., 1988) . Cell lysis buer contained 40 mM Tris-HCl pH 7.2, 20 mM EDTA, 100 mM NaCl and 0.5% SDS.
In vitro caspase assay
Seven murine cDNAs encoding caspases without prodomain and N-terminal His-tag, viz. caspase-1, caspase-2, caspase-3, caspase-6, caspase-7, caspase-11 and caspase-12, were cloned into a pLT10TH expression vector (Mertens et al., 1995) , expressed in E. coli and puri®ed to homogeneity by anity chromatography on Talon columns (Clontech Laboratories; Van de Craen et al., 1997; Schotte et al., 1998) . TXBP151 cDNA was cloned into a pGEM11ZF(+) expression vector (Promega Biotec, Madison, WI) and was used as a template to generate 35 S-methionine-labeled TXBP151 in a coupled transcription/translation reaction using a TNT kit (Promega Biotec). The proteolytic activity of caspases to 35 S-methionine-labeled TXBP151 was tested by mixing 300 ng of puri®ed caspase-x, 1 ml of 35 S-methionine-labeled TXBP151 and 18 ml of caspase maturation buer, containing 0.1% CHAPS, 50 mM HEPES pH 7.5 (KOH), 1 mM PMSF, 50 mM leupeptin and 20 mg/ml aprotinin, followed by incubation for 1.5 h at 378C. The reaction products were analysed by 12% SDS ± PAGE followed by autoradiography.
